Dialysis; ComplicationsNCT05939505
The Effect of Sujok Therapy on Symptom Burden and Comfort Level in Patients Undergoing Hemodialysis Treatment
A study testing Su Jok therapy and routine interventions in people with Dialysis; Complications, run by Candan DOGAN.
Trial summary
Many symptoms such as fatigue, muscle cramps, dry mouth, and headache that develop in patients due to the hemodialysis treatment process affect the quality of life and comfort of people. Sujok therapy is an effective method in symptom management. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Dialysis; Complications
- What is being tested?
- Su Jok therapy and routine interventions
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 140 participants
- Where
- No sites listed yet
- Study dates
- Sep 2023to Nov 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- be 18 years or older
- Receiving hemodialysis treatment for at least 6 months
- agreeing to participate in the study
Who cannot join
- Having food, metal and plastic allergies
- Having a cognitive and psychiatric diagnosis
- Loss of sensation and amputation that prevents application in the feet
Trial locations and contacts
No sites are listed yet.
About this study
Many symptoms such as fatigue, muscle cramps, dry mouth, and headache that develop in patients due to the hemodialysis treatment process affect the quality of life and comfort of people. Sujok therapy is an effective method in symptom management. Although sujok therapy is an uncomplicated acupressure, it has positive features such as being uncomplicated so that it can be applied by the patients themselves.
This study is planned as a single-blind placebo-controlled randomized trial. Research Hypotheses H0/1: Hydrotherapy has no effect on symptom burden in hemodialysis patients. H0/2: Hydrotherapy has no effect on hemodialysis comfort in hemodialysis patients.
Read more
H1/1: Hydrotherapy has an effect on symptom burden in hemodialysis patients. H1/2: Hydrotherapy has an effect on hemodialysis comfort in hemodialysis patients.
Inclusion criteria of volunteers
- 18 years or older
- To be on HD treatment for at least 6 months In our study, there are three groups as experimental, placebo and control groups.
Group application steps to be applied water jok therapy(experimental groups); The right foot in men and the left foot in women will be preferred, and the outer and inner surface of the foot will be massaged with a massage stick for an average of 3 minutes, then the middle of the area between the 3rd and 4th toes and the wrist line on the outer surface of the foot, which represents the kidney area in the macro system. The pain point will be determined with a diagnostic metal rod in the thoracic 12th spine and the area representing the lumbar 3rd spine region, and it will be fixed with the help of a Mexican bean seed patch in the appropriate size for the painful spot, and it will be ensured to remain in the area for at least 8 hours.
Group administration steps to be administered placebo ( Placebo Groups); It is planned that all the application steps will be the same as the group in which water jok therapy was applied, but instead of Mexican bean seeds, the use of red plastic number bean, which is used to improve the counting skill, is planned.
Control group application steps; It is planned to implement routine interventions applied in dialysis centers.
Sujok therapy and placebo application will be applied by the researcher during each dialysis session and it is planned to be carried out in a way to complete 14 sessions.
In the study, it is planned to use Dialysis Symptom Index together with Hemodialysis Comfort Scale Version Ⅱ for the groups before the application, after the seventh and fourteenth application.
Read the detailed description
The purpose of hemodialysis treatment; to remove metabolic wastes from the blood, to reduce symptoms and complications in patients, and to increase life expectancy and quality. During the hemodialysis treatment process, many comorbidities, complications and symptoms may occur in patients(1). The number of symptoms and the high load of effects in patients negatively affect their quality of life. In addition, life expectancy decreases and mortality rates increase in these patients (2). In order to reduce the burden of symptoms accompanying HD and increase the quality of life, it is necessary to ensure HD sufficiency and maintain physical, mental and biochemical well-being Su Jok therapy is defined as a modern interpretation of acupressure/acupuncture that can be applied to both acute and chronic diseases for symptom improvement and health promotion by using reflection points on the hands and feet(3). According to the Su Jok theory; There is energy flow and circulation in the body, and in case of illness, this energy flow is disrupted in the organ or a part of the body. With Su Jok therapy, it is argued that as a result of the application of various applicators (rings, metal starlets, magnets, etc.) and appropriate plant seeds to the hands and feet, which the energy system considers as stimulating points, the physically sick organ or body area is stimulated. It is stated that as a result of this stimulation, the energy in the body is activated and an improvement in symptoms is observed (4). Su Jok therapy, with the absence of any interference to the body, ease of application and learning, allows patients to apply it on their own with good counseling, and symptom management is also very effective. It is stated that nurses can apply Su Jok therapy as an integrative method in symptom management due to the simple and uncomplicated nature of Su Jok therapy and the need for invasive procedures (5).
Details of Study Design and Method This study is planned as a single-blind placebo-controlled randomized trial. The number of samples to be reached with patients who meet the criteria for inclusion in the study is planned to be the group in which sujok therapy was applied (37 people), the group that was administered placebo (37 people) and the control group (37 people) in which routine applications were made.
The researcher attended the Sujok Therapy Training given by the International Sujok Association between 08-28.11.2022. The content of the training consists of theoretical and practical information including the history of Su Jok, its mechanism of action, areas of use, basic information about Su Jok points.
Group application steps to be applied water jok therapy; The right foot in men and the left foot in women will be preferred, and the outer and inner surface of the foot will be massaged with a massage stick for an average of 3 minutes, then the middle of the area between the 3rd and 4th toes and the wrist line on the outer surface of the foot, which represents the kidney area in the macro system. The pain point will be determined with a diagnostic metal rod in the thoracic 12th spine and the area representing the lumbar 3rd spine region, and it will be fixed with the help of a Mexican bean seed patch in the appropriate size for the painful spot, and it will be ensured to remain in the area for at least 8 hours. It also plans insect (micro system) work simultaneously with the macro system, and the pain point is detected with a diagnostic metal rod in the lower 2/3 part of the 3rd node (the area representing the kidney region in the insect system) on the outer surface of the toes, and the appropriate size for the painful point is located in Mexico. bean seed will be fixed with the help of a plaster and it will be ensured that it remains in the area for at least 8 hours.
Group administration steps to be administered placebo; It is planned that all the application steps will be the same as the group in which water jok therapy was applied, but instead of Mexican bean seeds, the use of red plastic number bean, which is used to improve the counting skill, is planned.
The right foot in men and the left foot in women will be preferred, and the outer and inner surface of the foot will be massaged with a massage stick for an average of 3 minutes, then the 3rd and 4th feet will be applied on the outer surface of the foot, which represents the kidney region in the macro system.
In the middle part of the area between the fingers and the wrist line (the area representing the thoracic 12th spine and the lumbar 3rd spine region), the pain point is detected with a diagnostic metal stick, and a plastic red counting bean in size suitable for the painful spot is fixed with the help of a plaster. It will be ensured to stay in the area for 8 hours. It also plans insect (micro system) work simultaneously with the macro system, and the pain point is detected with a diagnostic metal rod in the lower 2/3 of the 3rd knuckle (the area representing the kidney region in the insect system) on the outer surface of the toes, and plastic of the appropriate size for the painful point is determined. The red counting bean will be detected with the help of a plaster and it will be ensured to stay in the area for at least 8 hours.
Painful spot detection does not change until it is detected in the first session and the procedure is completed.
Control group application steps; It is planned to implement routine interventions applied in dialysis centers.
Sujok therapy and placebo application will be applied by the researcher during each dialysis session and it is planned to be carried out in a way to complete 14 sessions.
In the study, it is planned to use Dialysis Symptom Index together with Hemodialysis Comfort Scale Version Ⅱ for the groups before the application, after the seventh and fourteenth application.
Randomization Method Since the practitioner and the researcher evaluating the data are the same person in this study, double-blind approach cannot be used. Randomization will be done via https://www.randomizer.org/.
Data Collection Tools In collecting the data of the research;
- Personal Information Form prepared by the researcher, containing the socio-demographic characteristics of the patients,
- With Hemodialysis Comfort Scale Version Ⅱ
- Dialysis Symptom Index will be used.
Personal Information Form The personal information form prepared by the researchers is a form that includes the socio-demographic variables of the patients (age, gender, marital status), duration of hemodialysis treatment, and chronic disease status.
Hemodialysis Comfort Scale Version-II Since the hemodialysis comfort scale, which was first developed by Orak et al. in 2017, was insufficient, the scale was developed by Koşar Şahin and his friend in 2019, and the Hemodialysis Comfort Scale-Version II scale was created. The scale is a 5-point Likert-type scale consisting of 26 items and six sub-dimensions(6,7).
Dialysis Symptom Index Developed by Weisbord et al. in 2004, this scale assesses physical and emotional symptoms and their severity. The Turkish validity and reliability of the scale was done by the Foreword, Usta Yeşilbalkan(8,9) .
Data Collection The pre-test data of the study were planned to be collected during July 2023, after a brief information about the study was given to the individuals receiving dialysis treatment by the researcher. Pre-test data will be collected by the researcher by face-to-face interview method. Application of data collection forms takes an average of 25 minutes. "Personal Information Form", "Hemodialysis Comfort Scale Version-II," "Dialysis Symptom Index" will be applied to individuals in the control and experimental groups to collect data.
Collection of Post-Test Data:
Patients in the experimental group will be given a total of 14 sessions of water jok, 3 times a week for 5 weeks. Post-test data will be collected by applying Dialysis Symptom Index together with Hemodialysis Comfort Scale Version Ⅱ after the 7th and 14th sessions.
Patients in the placebo group will be given a total of 14 sessions of water jok, 3 times a week for 5 weeks. Post-test data will be collected by applying Dialysis Symptom Index together with Hemodialysis Comfort Scale Version Ⅱ after the 7th and 14th sessions.
From the collection of pre-test data on patients in the control group who did not undergo any intervention. After the 7th and 14th Sessions, posttest data will be collected by applying the Dialysis Symptom Index together with the Hemodialysis Comfort Scale Version Ⅱ to the patients.
- Conditions
- Dialysis; Complications
- Being tested
- Su Jok therapy, placebo, routine interventions
- Keywords
- dialysis, Su Jok therapy, nursing
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Su Jok therapyOther
Sujok therapy will be applied with Mexican bean seeds 14 times with an interval of one day.
placeboOther
Instead of the Mexican bean seed applied in sujok therapy, plastic beans will be applied 14 times with an interval of one day.
routine interventionsOther
routine applications in the hemodialysis unit
| Study group | Role | What they receive |
|---|---|---|
| Su Jok Therapy Group | Experimental | Su jok Therapy According to Sujok therapy, sujok therapy will be applied 14 times with an interval of one day with Mexican bean seeds on the points representing the kidney. Receives: Other: Su Jok therapy; Other: routine interventions |
| placebo group | Placebo comparator | Instead of the Mexican bean seed used in Sujok therapy, plastic beans will be applied 14 times with an interval of one day. Receives: Other: placebo; Other: routine interventions |
| Control group | Active comparator | Routine applications will be made in the Dialysis Unit. Receives: Other: routine interventions |
What is being measured
The primary outcome is the main question the study is designed to answer.
Symptom burden in hemodialysis patients
Dialysis Symptom Index
Measured: pre-therapy, up to 3 weeks, up to 5 weeks
Secondary outcomes (1)
hemodialysis comfort in hemodialysis patients
Hemodialysis Comfort Scale
Measured: pre-therapy, up to 3 weeks, up to 5 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Jul 2023
- Study startSep 2023 (estimated)
- Primary completionOct 2023 (estimated)
- Study completionNov 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Dialysis; ComplicationsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- randomized-controlled,placebo
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 140 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Candan DOGAN
- Sponsor type
- University, hospital or other
- Collaborators
- Ataturk University
- Responsible party
- Sponsor-investigator, Candan DOGAN, Tokat Gaziosmanpasa University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05939505
- Sponsor's protocol ID
- GaziosmanpasaU-HMŞRLK-CD-01
- Status last verified
- Aug 2023
- First submitted
- 15 Jun 2023
- Last updated
- 18 Aug 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 18 Aug 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Sujok Therapy on Symptom Burden and Comfort Level in Patients Undergoing Hemodialysis Treatment
- ClinicalTrials.gov ID
- NCT05939505
- Acronym / sponsor ID
- GaziosmanpasaU-HMŞRLK-CD-01
- Conditions
- Dialysis; Complications
- Keywords
- dialysis, Su Jok therapy, nursing
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 140 participants (estimated)
- Lead sponsor
- Candan DOGANUniversity, hospital or other
- Collaborators
- Ataturk University
- Study start
- Sep 2023 (estimated)
- Primary completion
- Oct 2023 (estimated)
- Study completion
- Nov 2023 (estimated)
- First posted
- 11 Jul 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Many symptoms such as fatigue, muscle cramps, dry mouth, and headache that develop in patients due to the hemodialysis treatment process affect the quality of life and comfort of people. Sujok therapy is an effective method in symptom management. Although sujok therapy is an uncomplicated acupressure, it has positive features such as being uncomplicated so that it can be applied by the patients themselves.
This study is planned as a single-blind placebo-controlled randomized trial. Research Hypotheses H0/1: Hydrotherapy has no effect on symptom burden in hemodialysis patients. H0/2: Hydrotherapy has no effect on hemodialysis comfort in hemodialysis patients.
H1/1: Hydrotherapy has an effect on symptom burden in hemodialysis patients. H1/2: Hydrotherapy has an effect on hemodialysis comfort in hemodialysis patients.
Inclusion criteria of volunteers
- 18 years or older
- To be on HD treatment for at least 6 months In our study, there are three groups as experimental, placebo and control groups.
Group application steps to be applied water jok therapy(experimental groups); The right foot in men and the left foot in women will be preferred, and the outer and inner surface of the foot will be massaged with a massage stick for an average of 3 minutes, then the middle of the area between the 3rd and 4th toes and the wrist line on the outer surface of the foot, which represents the kidney area in the macro system. The pain point will be determined with a diagnostic metal rod in the thoracic 12th spine and the area representing the lumbar 3rd spine region, and it will be fixed with the help of a Mexican bean seed patch in the appropriate size for the painful spot, and it will be ensured to remain in the area for at least 8 hours.
Group administration steps to be administered placebo ( Placebo Groups); It is planned that all the application steps will be the same as the group in which water jok therapy was applied, but instead of Mexican bean seeds, the use of red plastic number bean, which is used to improve the counting skill, is planned.
Control group application steps; It is planned to implement routine interventions applied in dialysis centers.
Sujok therapy and placebo application will be applied by the researcher during each dialysis session and it is planned to be carried out in a way to complete 14 sessions.
In the study, it is planned to use Dialysis Symptom Index together with Hemodialysis Comfort Scale Version Ⅱ for the groups before the application, after the seventh and fourteenth application.
Detailed description
The purpose of hemodialysis treatment; to remove metabolic wastes from the blood, to reduce symptoms and complications in patients, and to increase life expectancy and quality. During the hemodialysis treatment process, many comorbidities, complications and symptoms may occur in patients(1). The number of symptoms and the high load of effects in patients negatively affect their quality of life. In addition, life expectancy decreases and mortality rates increase in these patients (2). In order to reduce the burden of symptoms accompanying HD and increase the quality of life, it is necessary to ensure HD sufficiency and maintain physical, mental and biochemical well-being Su Jok therapy is defined as a modern interpretation of acupressure/acupuncture that can be applied to both acute and chronic diseases for symptom improvement and health promotion by using reflection points on the hands and feet(3). According to the Su Jok theory; There is energy flow and circulation in the body, and in case of illness, this energy flow is disrupted in the organ or a part of the body. With Su Jok therapy, it is argued that as a result of the application of various applicators (rings, metal starlets, magnets, etc.) and appropriate plant seeds to the hands and feet, which the energy system considers as stimulating points, the physically sick organ or body area is stimulated. It is stated that as a result of this stimulation, the energy in the body is activated and an improvement in symptoms is observed (4). Su Jok therapy, with the absence of any interference to the body, ease of application and learning, allows patients to apply it on their own with good counseling, and symptom management is also very effective. It is stated that nurses can apply Su Jok therapy as an integrative method in symptom management due to the simple and uncomplicated nature of Su Jok therapy and the need for invasive procedures (5).
Details of Study Design and Method This study is planned as a single-blind placebo-controlled randomized trial. The number of samples to be reached with patients who meet the criteria for inclusion in the study is planned to be the group in which sujok therapy was applied (37 people), the group that was administered placebo (37 people) and the control group (37 people) in which routine applications were made.
The researcher attended the Sujok Therapy Training given by the International Sujok Association between 08-28.11.2022. The content of the training consists of theoretical and practical information including the history of Su Jok, its mechanism of action, areas of use, basic information about Su Jok points.
Group application steps to be applied water jok therapy; The right foot in men and the left foot in women will be preferred, and the outer and inner surface of the foot will be massaged with a massage stick for an average of 3 minutes, then the middle of the area between the 3rd and 4th toes and the wrist line on the outer surface of the foot, which represents the kidney area in the macro system. The pain point will be determined with a diagnostic metal rod in the thoracic 12th spine and the area representing the lumbar 3rd spine region, and it will be fixed with the help of a Mexican bean seed patch in the appropriate size for the painful spot, and it will be ensured to remain in the area for at least 8 hours. It also plans insect (micro system) work simultaneously with the macro system, and the pain point is detected with a diagnostic metal rod in the lower 2/3 part of the 3rd node (the area representing the kidney region in the insect system) on the outer surface of the toes, and the appropriate size for the painful point is located in Mexico. bean seed will be fixed with the help of a plaster and it will be ensured that it remains in the area for at least 8 hours.
Group administration steps to be administered placebo; It is planned that all the application steps will be the same as the group in which water jok therapy was applied, but instead of Mexican bean seeds, the use of red plastic number bean, which is used to improve the counting skill, is planned.
The right foot in men and the left foot in women will be preferred, and the outer and inner surface of the foot will be massaged with a massage stick for an average of 3 minutes, then the 3rd and 4th feet will be applied on the outer surface of the foot, which represents the kidney region in the macro system.
In the middle part of the area between the fingers and the wrist line (the area representing the thoracic 12th spine and the lumbar 3rd spine region), the pain point is detected with a diagnostic metal stick, and a plastic red counting bean in size suitable for the painful spot is fixed with the help of a plaster. It will be ensured to stay in the area for 8 hours. It also plans insect (micro system) work simultaneously with the macro system, and the pain point is detected with a diagnostic metal rod in the lower 2/3 of the 3rd knuckle (the area representing the kidney region in the insect system) on the outer surface of the toes, and plastic of the appropriate size for the painful point is determined. The red counting bean will be detected with the help of a plaster and it will be ensured to stay in the area for at least 8 hours.
Painful spot detection does not change until it is detected in the first session and the procedure is completed.
Control group application steps; It is planned to implement routine interventions applied in dialysis centers.
Sujok therapy and placebo application will be applied by the researcher during each dialysis session and it is planned to be carried out in a way to complete 14 sessions.
In the study, it is planned to use Dialysis Symptom Index together with Hemodialysis Comfort Scale Version Ⅱ for the groups before the application, after the seventh and fourteenth application.
Randomization Method Since the practitioner and the researcher evaluating the data are the same person in this study, double-blind approach cannot be used. Randomization will be done via https://www.randomizer.org/.
Data Collection Tools In collecting the data of the research;
- Personal Information Form prepared by the researcher, containing the socio-demographic characteristics of the patients,
- With Hemodialysis Comfort Scale Version Ⅱ
- Dialysis Symptom Index will be used.
Personal Information Form The personal information form prepared by the researchers is a form that includes the socio-demographic variables of the patients (age, gender, marital status), duration of hemodialysis treatment, and chronic disease status.
Hemodialysis Comfort Scale Version-II Since the hemodialysis comfort scale, which was first developed by Orak et al. in 2017, was insufficient, the scale was developed by Koşar Şahin and his friend in 2019, and the Hemodialysis Comfort Scale-Version II scale was created. The scale is a 5-point Likert-type scale consisting of 26 items and six sub-dimensions(6,7).
Dialysis Symptom Index Developed by Weisbord et al. in 2004, this scale assesses physical and emotional symptoms and their severity. The Turkish validity and reliability of the scale was done by the Foreword, Usta Yeşilbalkan(8,9) .
Data Collection The pre-test data of the study were planned to be collected during July 2023, after a brief information about the study was given to the individuals receiving dialysis treatment by the researcher. Pre-test data will be collected by the researcher by face-to-face interview method. Application of data collection forms takes an average of 25 minutes. "Personal Information Form", "Hemodialysis Comfort Scale Version-II," "Dialysis Symptom Index" will be applied to individuals in the control and experimental groups to collect data.
Collection of Post-Test Data:
Patients in the experimental group will be given a total of 14 sessions of water jok, 3 times a week for 5 weeks. Post-test data will be collected by applying Dialysis Symptom Index together with Hemodialysis Comfort Scale Version Ⅱ after the 7th and 14th sessions.
Patients in the placebo group will be given a total of 14 sessions of water jok, 3 times a week for 5 weeks. Post-test data will be collected by applying Dialysis Symptom Index together with Hemodialysis Comfort Scale Version Ⅱ after the 7th and 14th sessions.
From the collection of pre-test data on patients in the control group who did not undergo any intervention. After the 7th and 14th Sessions, posttest data will be collected by applying the Dialysis Symptom Index together with the Hemodialysis Comfort Scale Version Ⅱ to the patients.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 3
- Model description
- randomized-controlled,placebo
| Arm | Type | Receives |
|---|---|---|
| Su Jok Therapy Group | Experimental | Other: Su Jok therapy, Other: routine interventionsSu jok Therapy According to Sujok therapy, sujok therapy will be applied 14 times with an interval of one day with Mexican bean seeds on the points representing the kidney. |
| placebo group | Placebo comparator | Other: placebo, Other: routine interventionsInstead of the Mexican bean seed used in Sujok therapy, plastic beans will be applied 14 times with an interval of one day. |
| Control group | Active comparator | Other: routine interventionsRoutine applications will be made in the Dialysis Unit. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- be 18 years or older
- Receiving hemodialysis treatment for at least 6 months
- agreeing to participate in the study
Key exclusion criteria (3 listed)
- Having food, metal and plastic allergies
- Having a cognitive and psychiatric diagnosis
- Loss of sensation and amputation that prevents application in the feet
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Su Jok therapySujok therapy will be applied with Mexican bean seeds 14 times with an interval of one day. | Other | Su Jok Therapy Group |
| placeboInstead of the Mexican bean seed applied in sujok therapy, plastic beans will be applied 14 times with an interval of one day. | Other | placebo group |
| routine interventionsroutine applications in the hemodialysis unit | Other | Control group, Su Jok Therapy Group, placebo group |
Primary outcome
Symptom burden in hemodialysis patients
Time frame: pre-therapy, up to 3 weeks, up to 5 weeks
Dialysis Symptom Index
1 secondary outcome
hemodialysis comfort in hemodialysis patients
Time frame: pre-therapy, up to 3 weeks, up to 5 weeks
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Aug 2023.
- Individual participant dataSharing planned: Yes
Related trials for Dialysis; Complications
Recruiting
Guiding Optimal Blood Pressure Management in Peritoneal Dialysis Pilot Trial
End Stage Kidney Disease (ESKD), Hypertension (HTN)
Not yet recruiting
Days-Off Versus Daily Initial Peritoneal Dialysis Prescription
Kidney Failure
RecruitingPhase 3
Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism
Secondary Hyperparathyroidism, Chronic Kidney Disease
Not yet recruitingPhase 1/2
Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis
End Stage Renal Disease, Fatigue
Recruiting
Dry Weight Reduction Intervention Via Extra Ultrafiltration
Fluid Accumulation, Blood Pressure Management
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Questions about this trial
What is this clinical trial studying?
A study testing Su Jok therapy and routine interventions in people with Dialysis; Complications, run by Candan DOGAN.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 18 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Candan DOĞAN, lecturer (+90 (356) 250 00 11 ext. 3954, dogancandan70@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Symptom burden in hemodialysis patients (time frame: pre-therapy, up to 3 weeks, up to 5 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Aug 2023.